News

Bluerock High Income Fund Continues Strong Performance with New Distribution

Bluerock High Income Fund Continues Strong Performance with New Distribution

Bluerock High Income Fund Announces New Distribution

Bluerock High Income Institutional Credit Fund, often referred to as the High Income Fund, has recently informed its investors about the latest quarterly distribution. With a remarkable annualized distribution rate of 11.2%, this marks the Fund's thirteenth consecutive distribution announcement. Investors who held shares throughout the entire quarter will receive about $0.55 per share, contributing to the overall total distributions of approximately $8.76 per share since the Fund's inception.

Strategic Diversification in Portfolio Management

The High Income Fund is committed to a strategic approach in diversifying its portfolio. The Fund has been increasing its debt position allocations within the collateralized loan obligation (CLO) capital structure. This strategy is a vital aspect of their efforts to minimize risks while also ensuring attractive yield generation. As a result, the Fund has maintained a compelling risk-adjusted return profile, offering consistent income across varying market conditions.

Current Holdings and Portfolio Overview

The Fund currently holds positions in 120 CLOs, which represent an impressive aggregate underlying loan value of approximately $52.2 billion. This includes exposure to over 1,325 senior secured loans, diversified across numerous industries. The stated underlying holdings reflect data as of September 30, 2025, and may change over time. The net assets under management for the High Income Fund are around $189 million as of the same date.

Understanding Performance Metrics

It's important to note that returns presented are total net returns. This calculation considers changes in price and includes reinvesting income and capital gains distributions during the measured period, divided by the starting price. Notably, returns for longer periods are annualized to reflect their performance accurately. Investors are encouraged to reach out for performance data relevant to the most recent month-end.

Investment Costs and Fund Operations

The total annual operating expense ratio for the Fund varies by class, with Class A shares at 3.81%, Class C shares at 4.61%, and I shares at 3.66%. These fees reflect gross amounts before any waivers or reimbursements. The investment adviser has committed to reducing fees and absorbing expenses until early next year to keep net annual fund operating expenses manageable, thereby ensuring better returns for investors.

Potential Risks and Disclosures

Investing in the Bluerock High Income Fund involves inherent risks. Investors may experience little or no return and could lose part or all of their investment. Past performance is not an indicator of future results. In addition, shareholders should be mindful of the risks associated with limited liquidity, which only allows for quarterly share repurchase offers, offering limited opportunities for liquidity.

Institutional Support and Management

Bluerock has partnered with Clearlake Capital Asset Management, LLC, which has extensive experience in the CLO market, having overseen the issuance of around $40 billion in CLOs since 2001. This partnership supports the Fund's strategy of providing attractive, risk-adjusted returns and broad investor accessibility. The minimum investment requirement for public access shares is set at $2,500, with specific lower amounts for retirement plans.

Conclusion

The Bluerock High Income Institutional Credit Fund stands out as a robust option for investors seeking high current income and long-term capital appreciation. Thanks to comprehensive management, strategic risk reduction, and a consistent distribution policy, it continues to make strides in a competitive investment landscape.

Frequently Asked Questions

What is the annualized distribution rate for the Bluerock Fund?

The Bluerock High Income Fund has an annualized distribution rate of 11.2%.

When was the last distribution announced?

The most recent quarterly distribution was announced recently, marking the Fund's thirteenth consecutive distribution.

How does the Fund manage risks associated with its investments?

The Fund strategically diversifies its investments in CLOs and focuses on maintaining a low-risk profile while ensuring consistent income.

What is the minimum investment required to enter the Fund?

The minimum investment for Class A and C shares is $2,500, with $1,000 for retirement plans.

Who serves as the sub-advisor for the Fund?

The Fund partners with Clearlake Capital Asset Management, LLC, to manage its investments effectively.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Omega Point's MCP Secures Anthropic Verification

Updated Category News Views 25

In a world where investment decisions ride on razor-thin margins, Omega Point's MCP gains top-tier verification. Anthropic's seal of approval is stamped firmly on it, signalling to the wise investors out there that this engine ain't smoking mirrors. Since May, this player has been doing the rounds, but now, with Anthropic’s verification, it’s like Omega Point just...

Continue Reading
Wagner Logistics Gears Up for Major Expansion in Liberty

Updated Category News Views 34

Imagine waking up to news like this: Wagner Logistics is laying down some serious roots in Liberty, MO. They’ve snagged a deal with a local manufacturer that’s got them renting out over 830,000 square feet of warehouse space. Seems Wagner's got a knack for living large. More Than Just a Warehouse Gig Wagner's not just popping up another dusty shelf space; they're...

Continue Reading
JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 24

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 30

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 23

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 23

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 25

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
A1 Refrigeration Keeps East Texas Homes Comfortable Year-Round

Updated Category News Views 32

Homeowners in East Texas would agree: the last thing you want is your HVAC system throwing a tantrum when you're in the thick of a scorching summer or a biting winter. That's where A1 Refrigeration & Air Conditioning steps in, making sure folks in Jasper, Brookeland, and Kirbyville aren't left sweating bullets or shivering in their boots. Preventive Maintenance: A...

Continue Reading
Marshall Goldman Expands Footprint with Marino Acquisition

Updated Category News Views 40

Revving Up in Florida: Marshall Goldman's Strategic Leap If you're tuned into the luxury car scene, you probably already heard Marshall Goldman is making moves into Florida. Buying Marino Performance Motors of West Palm Beach isn't just another notch on their belt—it's a strategic leap into their second-largest market. This ain't merely about showroom floor space. Think...

Continue Reading
FCS Drives Key FDA Approvals in Cancer Treatment

Updated Category News Views 28

Florida Cancer Specialists: Changing the Cancer Treatment Game Some organizations toot their horns, but every now and then, a group truly shakes up the playing field. Take Florida Cancer Specialists & Research Institute (FCS), for instance. Over years of relentless research, FCS has nailed its role in securing two significant FDA approvals aimed at expanding treatment...

Continue Reading

Top 5 Most Recently Viewed Articles

Imac Holdings Navigates Troubling Times and Financial Strains

Updated Category News Views 309

Imac Holdings Faces 52-Week Low in Turbulent Market Imac Holdings Inc (NASDAQ: IMAC) is experiencing significant challenges as its stock price has hit a 52-week low of $0.96. This decline represents a staggering 52.36% drop in its stock value over the past year. Investors are feeling the pressure as the company fights against an array of market adversities. The current...

Continue Reading
Kiniksa Pharmaceuticals' Upgraded Price Target Sparks Interest

Updated Category News Views 81

Kiniksa Pharmaceuticals Receives Price Target Upgrade Recently, Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) experienced a surge in interest following Evercore ISI's adjustment of its price target on the company’s stock. The new target is set at $35, an increase from the previous $30, and comes alongside a retained Outperform rating. This update is a positive reflection...

Continue Reading
Investigation Launched into American Woodmark Corporation Sale

Updated Category News Views 196

New Investigation Announced for American Woodmark Corporation Recently, attention has been drawn to American Woodmark Corporation (NASDAQ: AMWD) as a class action law firm starts investigating the terms of its proposed sale to MasterBrand, Inc. This investigation arises from the concern that the sale may not be beneficial for shareholders, presenting questions about...

Continue Reading
Virax Biolabs' Strategic Direction and Innovations for 2026

Updated Category News Views 202

Virax Biolabs' Commitment to Innovation and Progress Virax Biolabs' proprietary diagnostic technology targets post-acute infection syndromes (PAIS), including the challenging Long COVID. This year is critical for data emergence, especially after numerous clinical milestones achieved recently. Virax Biolabs Group Limited (NASDAQ: VRAX), a pioneering biotechnology firm, has...

Continue Reading
Aebi Schmidt Group Declares Historic Dividend Following Nasdaq Listing

Updated Category News Views 123

Aebi Schmidt Group Makes History with First Dividend Payment Aebi Schmidt Group (NASDAQ: AEBI) has taken a monumental step in its journey by declaring its first-ever dividend payout. As a leader in the specialty vehicles sector, this announcement marks a significant milestone for the company. Details of the First Dividend The company’s decision follows its successful...

Continue Reading